Skip to content

Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective Study

Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03066037
Acronym
RetroBlock
Enrollment
83
Registered
2017-02-28
Start date
2009-01-01
Completion date
2016-11-13
Last updated
2017-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Cluster Headache, Neuropathic Pain, Post-Zoster Neuralgia, Post Zoster Pain, Trigeminal Neuralgia

Keywords

regional-anaesthesiological infiltration, block series, invasive pain treatment

Brief summary

There is a significant debate whether local infiltration techniques may be a method to treat complicated chronic pain syndromes, e.g. refractory headache. Until now there is a lack of evidence regarding efficacy of this treatment especially in long term follow up. Similarly, indication and management are under debate. Aim of this trial is to analyse pain scores during first treatment with anaesthesiological infiltration series.

Interventions

PROCEDUREregional-anaesthesiological infiltration

Patients with therapy refractory chronic pain are treated with local infiltration techniques using e.g. local anaesthetics, opioids or drug combinations. Targeted structures are e.g. Ganglion stellatum, Ganglion pterygopallatinum, Trigeminal nerve branches (V1-V3). Patients receive a context- sensitive number of blocks in a series of infiltrations depenting on their pain course.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with chronic pain disease undergoing regional-anaesthesiological infiltration series

Exclusion criteria

* pregnancy * patients in legal custody * age \<18 years

Design outcomes

Primary

MeasureTime frameDescription
NRS reduction during therapy2 weeksReduction (relative and absolute) of pain during series of infiltrations comparing NRS scores before and after infiltrations

Secondary

MeasureTime frameDescription
Number of blocks in a series4 weeksNumber of blocks in a series to achieve the targeted NRS reduction
Time till recurrent pain24 weeksTime until a new series of blocks is requested by the patient
clinical course of pain2 weeksNRS development during series of infiltrations
type of infiltration2 weekslocation of infiltrations with medication used
co-parameters of pain chronification2 weeksco-factors of pain like co-morbidity, duration of pain disease, psychological diseases and association with primary outcome

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026